EIF2S1 Antikörper (AA 123-137)
Kurzübersicht für EIF2S1 Antikörper (AA 123-137) (ABIN2620309)
Target
Alle EIF2S1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 123-137
-
Kreuzreaktivität (Details)
- No cross reactivity with other proteins.
-
Aufreinigung
- Immunogen affinity purified
-
Immunogen
- A synthetic peptide corresponding to a sequence in the middle region of human EIF2S1(123-137aa KDEQLESLFQRTAWV).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2 HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide per 100 μg antibody.
-
Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- At -20°C for 1 year. After reconstitution, at 4°C for 1 month. It can also be aliquotted and stored frozen at -20°C for a longer time.Avoid freeze-thaw cycles.
-
-
- EIF2S1 (Eukaryotic Translation Initiation Factor 2 Subunit 1 (EIF2S1))
-
Andere Bezeichnung
- EIF2S1
-
Hintergrund
-
Name/Gene ID: EIF2S1
Synonyms: EIF2S1, EIF-2-alpha, EIF-2alpha, EIF2 alpha, EIF2, EIF-2, EIF-2A -
Gen-ID
- 1965
-
Pathways
- Ribonucleoprotein Complex Subunit Organization, ER-Nucleus Signaling, Hepatitis C
Target
-